Possible role of natural killer cells in pemphigus vulgaris - Preliminary observations

Clinical and Experimental Immunology

Volumn 152, Issue 3, 2008, Pages 472-481

  Stern, J N H ^a   Keskin, D B ^a   Barteneva, N ^a   Zuniga, J ^a   Yunis, E J ^a   Ahmed, A R ^a  

^a NEW ENGLAND BAPTIST HOSPITAL   (United States)

Author keywords

B cell; MHC class II; Natural killer cells; T lymphocyte

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL STIMULATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPHOCYTE CULTURE; MALE; NATURAL KILLER CELL; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SUPERNATANT; T LYMPHOCYTE ACTIVATION;

AGED; ANTIGEN PRESENTATION; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; DESMOGLEIN 3; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PEMPHIGUS; RECEPTORS, IMMUNOLOGIC; SKIN;

EID: 43349085319     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03638.x     Document Type: Article

References (39)

1. Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin 1993 11 : 429 52.
2. Wucherpfennig KW, Yu B, Bhol K et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 1995 92 : 11935 9.
3. Denning MF, Guy SG, Ellerbroek SM, Norvell SM, Kowalczyk AP, Green KJ. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C. Exp Cell Res 1998 239 : 50 9.
4. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982 306 : 1189 96.
5. Storer JS, Galen WK, Nesbitt LT Jr, DeLeo VA. Neonatal pemphigus vulgaris. J Am Acad Dermatol 1982 6 : 929 32.
6. Hertl M, Karr RW, Amagai M, Katz SI. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals. J Invest Dermatol 1998 110 : 388 92.
7. Veldman CM, Gebhard KL, Uter W et al. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J Immunol 2004 172 : 3883 92.
8. Cooper MA, Fehniger TA, Turner SC et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56 (bright) subset. Blood 2001 97 : 3146 51.
9. Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL. Viral evasion of natural killer cells. Nat Immunol 2002 3 : 1006 12.
10. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001 22 : 633 40.
11. Campbell JJ, Qin S, Unutmaz D et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001 166 : 6477 82.
12. Frey M, Packianathan NB, Fehniger TA et al. Differential expression and function of 1-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 1998 161 : 400 8.
13. Fehniger TA, Cooper MA, Nuovo GJ et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003 101 : 3052 7.
14. Jacobs R, Hintzen G, Kemper A et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001 31 : 3121 7.
15. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol 2004 25 : 47 52.
16. Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic auto antibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA 1995 92 : 5239 43.
17. Bhol KC, Desai A, Kumari S, Colon JE, Ahmed AR. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Clin Immunol 2001 100 : 172 80.
18. Amagai M, Ahmed AR, Kitajima Y et al. Are desmoglein auto antibodies essential for the immunopathogenesis of pemphigus vulgaris, or just 'witnesses of disease'? Exp Dermatol 2006 15 : 815 31.
19. Chapoval AI, Ni J, Lau JS et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001 2 : 269 74.
20. Hanna J, Gonen-Gross T, Fitchett J et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 2004 114 : 1612 23.
21. Dalbeth N, Gundle R, Davies RJ, Lee YC, McMichael AJ, Callan MF. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004 173 : 6418 26.
22. Hilbert DM, Cancro MP, Scherle PA et al. T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells. J Immunol 1989 143 : 4019 24.
23. Freeman GJ, Freedman AS, Rabinowe SN et al. Interleukin 6 gene expression in normal and neoplastic B cells. J Clin Invest 1989 83 : 1512 8.
24. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004 5 : 1219 26.
25. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001 106 : 255 8.
26. Mellman I, Turley SJ, Steinman RM. Antigen processing for amateurs and professionals. Trends Cell Biol 1998 8 : 231 7.
27. Munz C, Dao T, Ferlazzo G, de Cos MA, Goodman K, Young JW. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 2005 105 : 266 73.
28. Nishimoto N. Cytokine signal regulation and autoimmune disorders. Autoimmunity 2005 38 : 359 67.
29. Richards HB, Satoh M, Shaw M, Libert C, Poli V, Reeves WH. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 1998 188 : 985 90.
30. Kawano Y, Noma T, Kou K, Yoshizawa I, Yata J. Regulation of human IgG subclass production by cytokines: human IgG subclass production enhanced differentially by interleukin-6. Immunology 1995 84 : 278 84.
31. O'Toole EA, Mak LL, Guitart J et al. Induction of keratinocyte IL-8 expression and secretion by IgG auto antibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol 2000 119 : 217 24.
32. Brandt E, Muller-Alouf H, Desreumaux P, Woerly G, Colombel JF, Capron M. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease. Eur Cytokine Netw 1998 9 : 647 53.
33. Gilli UO, Schneider MK, Loetscher P, Seebach JD. Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. Transplantation 2005 79 : 1324 31.
34. Wilkinson JE, Smith CA, Suter MM, Falchek W, Lewis RM. Role of plasminogen activator in pemphigus vulgaris. Am J Pathol 1989 134 : 561 9.
35. Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 2004 172 : 7684 93.
36. Lit LC, Wong CK, Tam LS, Li EK, Lam CW. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 2006 65 : 209 15.
37. Bartosik-Psujek H, Stelmasiak Z. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease. Eur J Neurol 2005 12 : 49 54.
38. Azuz-Lieberman N, Markel G, Mizrahi S et al. The involvement of NK cells in ankylosing spondylitis. Int Immunol 2005 17 : 837 45.
39. Takahashi H, Amagai M, Tanikawa A et al. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J Invest Dermatol 2007 127 : 324 30.